R
Overview
Regent Surgical Health develops and manages ambulatory surgery centers (ASCs) through joint ventures with hospitals and physicians. It handles day-to-day operations such as staffing, billing, and regulatory compliance, and shares profits from the partnerships. By focusing on outpatient facilities, it helps health systems extend their brands and physicians run efficient settings for procedures. Its goal is to build a network of high-performing ASCs that expands access to outpatient surgery and improves operational efficiency for partners.
Work here?Claim your company
Simplify's take
What believers are saying
- Penn, IBX, and Regent launched at least 18 ASCs on September 24, 2026.
- CMS removed 285 inpatient-only procedures in 2026, expanding outpatient volume immediately.
- Regent’s Arizona partnership expands cardiovascular and multispecialty care across Phoenix through physician groups.
What critics are saying
- The first Penn-IBX centers open in 2027, delaying revenue and proving execution risk.
- Regent depends on regulators approving new ASCs, especially Pennsylvania, New Jersey, and Delaware.
- If surgeons skip the new centers, the 18-site model fails to scale.
What makes Regent Surgical unique
- Regent co-owns Penn Medicine-IBX’s first-in-kind ASC company, pairing payer, health system, operator.
- It manages nearly 40 centers across 15 states, proving multi-market operating scale.
- Its physician advisory board and resident privileges accelerate surgeon adoption and training.
Help us improve and share your feedback! Did you find this helpful?